BG
FLNA

BlackRock Group’s Filana Therapeutics FLNA Stock Holding History

BlackRock Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,981
Closed -$115K – 2861
2014
Q1 		$115K Buy
+2,981
New +$105K ﹤0.01% 2552
2013
Q4 		– Sell
-6,248
Closed -$119K – 2765
2013
Q3 		$119K Buy
+6,248
New +$109K ﹤0.01% 2580

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Group's FLNA Position: Q2 2014 in Review

BlackRock Group sold out of Filana Therapeutics (FLNA) in Q2 2014, closing a stake of 2,981 shares — an estimated $115K sold.

BlackRock Group first reported a position in FLNA in Q3 2013 and held it in 2 quarters. The position peaked at $119K in Q3 2013. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2014.

  • BlackRock Group reported no remaining Filana Therapeutics position as of Q2 2014 after selling out during the quarter.
  • BlackRock Group sold 2,981 Filana Therapeutics shares in Q2 2014, an estimated $115K.
  • BlackRock Group first reported a position in Filana Therapeutics in Q3 2013 and held it in 2 quarters.
  • BlackRock Group's Filana Therapeutics position peaked at $119K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2014.

Based on BlackRock Group's 13F filing for Q2 2014, filed 6 Aug 2014.